Home > Insider Trading > Filing (0001127602-13-020713)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
97745	Thermo Fisher Scientific Inc.	TMO	Measuring & Controlling Devices, Nec (3829)	042209186

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1216070	H Seth Hoogasian	81 Wyman Street Waltham MA 02451	Sr. Vp, Gen. Counsel & Sec.	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-06-17	18,225	$49.49	79,960	No	4	M	Direct
Common Stock	Acquisiton	2013-06-17	9,534	$36.10	89,494	No	4	M	Direct
Common Stock	Disposition	2013-06-17	35,431	$85.59	54,063	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2013-06-17	18,225	$0.00	18,225	$49.49
Common Stock	Stock Option (Right to Buy)	Disposition	2013-06-17	9,534	$0.00	9,534	$36.10

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,075	2011-03-05	2017-03-05	No	4	M	Direct
0		2016-02-26	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	407	Indirect	By 401(k)

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 7, 2013.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.29 to $85.78, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option is exercisable in four equal annual installments. The first, second and third installments became exercisable on March 5, 2011, 2012, and 2013, and the next installment becomes exercisable on March 5, 2014.
The option vested in three equal installments on February 26, 2010, 2011 and 2012.